Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Primary Care

Journal Scan / Research · May 02, 2022

Low-Dose Triple Combination Antihypertensive Therapy vs Usual Care and Time at Target Blood Pressure

JAMA Cardiology


Additional Info

JAMA Cardiology
Association of Low-Dose Triple Combination Therapy vs Usual Care With Time at Target Blood Pressure: A Secondary Analysis of the TRIUMPH Randomized Clinical Trial
JAMA Cardiol 2022 Apr 13;[EPub Ahead of Print], SR Gnanenthiran, N Wang, GL Di Tanna, A Salam, R Webster, HA de Silva, R Guggilla, S Jan, PK Maulik, N Naik, V Selak, S Thom, D Prabhakaran, AE Schutte, A Patel, A Rodgers

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading